Page last updated: 2024-10-30

losartan and Colitis, Granulomatous

losartan has been researched along with Colitis, Granulomatous in 1 studies

Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position

Research Excerpts

ExcerptRelevanceReference
"Losartan was administered to male adult C57BL/6 J mice 2 weeks prior to the induction of colitis, and images of the whole colon were captured to record changes, scored according to a microscopic scoring system, and reverse transcription-quantitative polymerase chain reaction were performed in order to investigate colonic inflammation."1.43AT1R blocker losartan attenuates intestinal epithelial cell apoptosis in a mouse model of Crohn's disease. ( Liu, TJ; Shi, YY; Wang, EB; Zhao, Q; Zhu, T, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, TJ1
Shi, YY1
Wang, EB1
Zhu, T1
Zhao, Q1

Other Studies

1 other study available for losartan and Colitis, Granulomatous

ArticleYear
AT1R blocker losartan attenuates intestinal epithelial cell apoptosis in a mouse model of Crohn's disease.
    Molecular medicine reports, 2016, Volume: 13, Issue:2

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3;

2016